Riding high: Australia has potential to be world leader in medicinal cannabis
Australia is tipped to become a potential leader in the booming global market for medicinal cannabis, due to the country’s...
News
Medicinal Cannabis
News
Emyria’s data-backed cannabinoid treatments are changing lives
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical...
Webcast
Cann Group Investor Briefing – 16 December
Cann Group (ASX: CAN) is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale...
Webcast
The Insider – 16 December
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to their industries...